Analysis: Remus Pharmaceuticals Ltd.

NSE:REMUS Pharma - Others Market cap: ₹1.1K cr

Research report

companyname: Remus Pharmaceuticals Limited ticker: REMUS sector: Pharmaceuticals – export marketing, branding and distribution of finished dosage formulations (asset-light, no owned manufacturing) Remus Pharmaceuticals is an asset-light Indian pharmaceutical company that develops, registers, brands and distributes finished dosage formulations in emerging markets. It owns no factories. Roughly 90-95% of its products are developed and manufactured by third-party contract manufacturers, while Remu...

Read the full report →
RS rating: 82 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Remus Pharmaceuticals Ltd. and 4,900+ companies.

Sign in
5-day free pass. No card required.